Percutaneous Nephrolithotomy for Kidney Stones in Patients with Hematological Malignancy
dc.contributor.author | Kuzgunbay, Baris | |
dc.contributor.author | Turunc, Tahsin | |
dc.date.accessioned | 2019-09-11T08:28:50Z | |
dc.date.available | 2019-09-11T08:28:50Z | |
dc.date.issued | 2016 | |
dc.description.abstract | To define the alterations in the outcomes of percutaneous nephrolithotomy (PNL) operations for kidney stones in patients with history of hematological malignancy (HM). Material and Method: Between 2000 and 2013, 1700 adult patients underwent PNL for the treatment of kidney stones in our institution. Four of these patients had a history of HM and considered to be HM group (n=4). Ten elderly (>65 years) patients who had no history of operation, HM or any other co-morbide diseases were chosen as the control group (n=10). Surgical parameters, success rates, additional treatments and complications were evaluated. Results: Statistical analyses showed no significant differences between HM and control group according to stone area, operation time, fluoroscopy time, hospitalization time,Delta Hb, blood transfusion rates and INR values (p>0.05). Statistical analyses revealed no significant differences between HM and control groups according to the success rates (p=0.470). Statistical analyses revealed no significant difference between groups for additional treatment requirements (p=0.882). No major perioperative complication was seen in both of the groups. Discussion: The treatment of kidney stone disease by PNL in patients with hematological malignancy is feasible, safe and effective. However, close cooperation with the Hematology Department before the operation is mandatory. | en_US |
dc.identifier.endpage | 429 | en_US |
dc.identifier.issn | 1309-0720 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.scopus | 2-s2.0-84962019849 | en_US |
dc.identifier.startpage | 425 | en_US |
dc.identifier.uri | http://www.bayrakol.org/en/2016/july2016/original-article/item/1328-percutaneous-nephrolithotomy-for-kidney-stones-in-patients-with-hematological-malignancy | |
dc.identifier.uri | http://hdl.handle.net/11727/3880 | |
dc.identifier.volume | 7 | en_US |
dc.identifier.wos | 000376567100001 | en_US |
dc.language.iso | eng | en_US |
dc.relation.isversionof | 10.4328/JCAM.2888 | en_US |
dc.relation.journal | JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Percutaneous Nephrolithotomy | en_US |
dc.subject | Kidney Stones | en_US |
dc.subject | Hematological Malignancy | en_US |
dc.title | Percutaneous Nephrolithotomy for Kidney Stones in Patients with Hematological Malignancy | en_US |
dc.type | article | en_US |